225 related articles for article (PubMed ID: 19644018)
41. Combination of thiazolidinedione and hydralazine suppresses proliferation and induces apoptosis by PPARγ up-expression in MDA-MB-231 cells.
Jiang Y; Huang Y; Cheng C; Lu W; Zhang Y; Liu X; Zou L; Ben Q; Shen A
Exp Mol Pathol; 2011 Dec; 91(3):768-74. PubMed ID: 21930124
[TBL] [Abstract][Full Text] [Related]
42. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
Uchimura K; Nakamuta M; Enjoji M; Irie T; Sugimoto R; Muta T; Iwamoto H; Nawata H
Hepatology; 2001 Jan; 33(1):91-9. PubMed ID: 11124825
[TBL] [Abstract][Full Text] [Related]
43. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
Desreumaux P; Dubuquoy L; Nutten S; Peuchmaur M; Englaro W; Schoonjans K; Derijard B; Desvergne B; Wahli W; Chambon P; Leibowitz MD; Colombel JF; Auwerx J
J Exp Med; 2001 Apr; 193(7):827-38. PubMed ID: 11283155
[TBL] [Abstract][Full Text] [Related]
44. 9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.
Singh RR; Gururaj AE; Vadlamudi RK; Kumar R
J Biol Chem; 2006 Jun; 281(22):15394-404. PubMed ID: 16574651
[TBL] [Abstract][Full Text] [Related]
45. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
[TBL] [Abstract][Full Text] [Related]
46. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
Tanosaki S; Ikezoe T; Heaney A; Said JW; Dan K; Akashi M; Koeffler HP
Breast Cancer Res Treat; 2003 Jun; 79(3):335-45. PubMed ID: 12846418
[TBL] [Abstract][Full Text] [Related]
47. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN
Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805
[TBL] [Abstract][Full Text] [Related]
48. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
49. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
Liu H; Zang C; Fenner MH; Possinger K; Elstner E
Breast Cancer Res Treat; 2003 May; 79(1):63-74. PubMed ID: 12779083
[TBL] [Abstract][Full Text] [Related]
50. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
[TBL] [Abstract][Full Text] [Related]
51. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.
Seargent JM; Yates EA; Gill JH
Br J Pharmacol; 2004 Dec; 143(8):933-7. PubMed ID: 15533890
[TBL] [Abstract][Full Text] [Related]
52. Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.
Mody M; Dharker N; Bloomston M; Wang PS; Chou FS; Glickman TS; McCaffrey T; Yang Z; Pumfery A; Lee D; Ringel MD; Pinzone JJ
Endocr Relat Cancer; 2007 Jun; 14(2):305-15. PubMed ID: 17639046
[TBL] [Abstract][Full Text] [Related]
53. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
[TBL] [Abstract][Full Text] [Related]
54. The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism.
Ghorbani A; Nazari M; Jeddi-Tehrani M; Zand H
Eur J Nutr; 2012 Feb; 51(1):39-46. PubMed ID: 21445621
[TBL] [Abstract][Full Text] [Related]
55. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
Pon CK; Firth SM; Baxter RC
Mol Cell Endocrinol; 2015 Jan; 399():354-61. PubMed ID: 25449421
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.
Ray DM; Spinelli SL; Pollock SJ; Murant TI; O'Brien JJ; Blumberg N; Francis CW; Taubman MB; Phipps RP
Thromb Haemost; 2008 Jan; 99(1):86-95. PubMed ID: 18217139
[TBL] [Abstract][Full Text] [Related]
57. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
58. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
59. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.
Suzui M; Shimizu M; Masuda M; Lim JT; Yoshimi N; Weinstein IB
Mol Cancer Ther; 2004 Mar; 3(3):309-16. PubMed ID: 15026551
[TBL] [Abstract][Full Text] [Related]
60. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
Konopleva M; Elstner E; McQueen TJ; Tsao T; Sudarikov A; Hu W; Schober WD; Wang RY; Chism D; Kornblau SM; Younes A; Collins SJ; Koeffler HP; Andreeff M
Mol Cancer Ther; 2004 Oct; 3(10):1249-62. PubMed ID: 15486192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
